Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 25100-12-3 | MDL No. : | MFCD00012565 |
Formula : | C6H14ClNO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | SSVAHXZUFFSFER-UHFFFAOYSA-N |
M.W : | 151.63 g/mol | Pubchem ID : | 3084432 |
Synonyms : |
|
Num. heavy atoms : | 9 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 1.0 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 39.34 |
TPSA : | 32.26 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.86 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 1.92 |
Log Po/w (WLOGP) : | 2.1 |
Log Po/w (MLOGP) : | 1.38 |
Log Po/w (SILICOS-IT) : | 0.74 |
Consensus Log Po/w : | 1.23 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.92 |
Solubility : | 1.81 mg/ml ; 0.0119 mol/l |
Class : | Very soluble |
Log S (Ali) : | -2.22 |
Solubility : | 0.911 mg/ml ; 0.00601 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -0.74 |
Solubility : | 27.8 mg/ml ; 0.183 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.78 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 498532-32-4 ]
(1R,3S)-rel-Cyclohexane-1,3-diamine dihydrochloride
Similarity: 0.67
[ 33483-66-8 ]
cis-4-Methylcyclohexanamine hydrochloride
Similarity: 0.64
[ 33483-65-7 ]
trans-4-Methylcyclohexanamine hydrochloride
Similarity: 0.64
[ 5471-54-5 ]
1-Cyclohexylpropan-2-amine hydrochloride
Similarity: 0.64
[ 498532-32-4 ]
(1R,3S)-rel-Cyclohexane-1,3-diamine dihydrochloride
Similarity: 0.67
[ 101689-05-8 ]
(R)-Pentan-2-amine hydrochloride
Similarity: 0.65
[ 50632-53-6 ]
N-Isopropylhydroxylamine hydrochloride
Similarity: 0.65
[ 216237-52-4 ]
(S)-Pentan-2-amine hydrochloride
Similarity: 0.65
[ 50632-53-6 ]
N-Isopropylhydroxylamine hydrochloride
Similarity: 0.65
[ 57497-39-9 ]
N-(tert-Butyl) hydroxylamine hydrochloride
Similarity: 0.59
[ 14691-88-4 ]
4-Amino-2,2,6,6-tetramethylpiperidine 1-Oxyl
Similarity: 0.56